The firm's automated AIR sample prep technology quickly images, sorts, and isolates single cells for downstream molecular analysis.
Researchers found that ADAR works by stabilizing the FAK gene, which is one of a subset involved in cell migration pathways.
Considering the widespread use of the cell line, these findings could have significant implications for the research community.
The microarray facilitates drug screening in cancer stem cells and other rare cell populations.
A team of scientists at the Broad Institute has developed a new cell microarray and validated it as a potential functional genomics tool by using it to screen cells for drug resistance in melanoma.
By Justin Petrone
The National Institutes of Health has awarded $1.5 million to a team of researchers at Arizona State University to develop a high-throughput, live cell array for metabolic studies.
Led by scientists at McGill University in Montreal, the team designed a way to measure transcriptional changes in real time in single mammalian cells, and claims the approach could be used to study cell proliferation, differentiation, and apoptosis.
The Italian biochip firm has established an office in San Diego from which it aims to target the US market and eventually steer its DEPArray cell analysis platform into the clinic.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.